## Respiratory, Effusion %%
Causes for a pleural exudate?
- Pneumonia
- Neoplasm
- Tuberculosis
- Sarcoidosis
- Infarction
- Pancreatitis
- Rheumatoid arthritis, Systemic lupus erythematous
- Nitrofurantoin, bromocriptine
- Radiation

## Respiratory, Effusion %%
Causes for a pleural transudate?
- Cardiac failure
- Nephrotic syndrome
- Liver failure
- Meigs' syndrome (ovarian fibroma)
- Hypothyroidism

## Respiratory, Effusion %%
What is Light's criteria?
- To determine whether an effusion is transudate vs exudate
- Pleural protein/Serum protein > 0.5
- Pleural LDH/Serum LDH > 0.6
- Pleural LDH > 2/3 upper limit of normal Serum LDH

## Respiratory, Effusion %%
Other criteria for assessing effusions?
- Pleural cholesterol > 1.165 mmol/L
- Pleural LDH > 0.45 upper limit of normal Serum LDH
- Pleural protein > 29 g/L

## Respiratory, Pulmonary Fibrosis %%
Causes of lower lobe fibrosis?
- Rheumatoid arthritis
- Asbestosis
- Scleroderma
- Crytogenic fibrosing alveolitis
- Bleomycin/Nitrofurantoin/Hydralazine/Methotrexate

## Respiratory, Pulmonary Fibrosis %%
Causes of upper lobe fibrosis?
- Histiocytosis
- Ankylosing spondylitis
- Silicosis
- Tuberculosis
- Radiation
- Allergic bronchopulmonary aspergillosis
- Pneumoconiosis
- Sarcoidosis

## Respiratory, Pulmonary Fibrosis %%
Radiological findings of UIP?
- Subpleural, bibasal reticular opacities
- Traction bronchiectasis
- Honeycombing

## Respiratory, COPD %%
Diagnostic criteria for COPD?
- FEV1/FVC ratio < 0.7
- Irreversible/partially bronchodilator responsive (deltaFEV1 <= 400mL)
- Presence of typical symptoms and risk factors (dyspnoea, cough +/- productive, smoking)

## Respiratory, COPD %%
Severity of COPD?
- Mild:
-- Few symptoms
-- Dyspnoea on moderate exertion
-- Little to no effect on ADLs
-- FEV1 ~ 60 - 80% predicted
- Moderate:
-- Increasing dyspnoea
-- SOB walking flats
-- Cough & sputum
-- Infections with steroid use
-- FEV1 ~ 40 - 59% predicted
- Severe:
-- Dyspnoea on minimal exertion
-- Severely limited ADLs
-- Chronic cough
-- FEV1 < 40% predicted

## Respiratory, Bronchiectasis %%
Causes of bronchiectasis?
- Pulmonary infections, esp. Childhood recurrent infections, Mycobacterial, Nocardia
- Primary ciliary dysfunction, e.g. Kartagener's
- CF
- ABPA
- Airway obstruction, e.g. foreign body, tumour
- Primary or secondary immunodeficiency, e.g. hypogammaglobulinaemia

## Respiratory, Lobectomy %%
Indications for a lobectomy?
- Bronchiectasis
- Malignancy
- TB
- Lung abscess
- CF
- Unknown solitary lung nodule

## Respiratory, Pulmonary Hypertension %%
Signs of pulmonary hypertension?
- Loud P2
- Palpable P2 (severe)
- Prominent a waves
- Prominent v waves (once TR occurs)
- RV heave
- TR murmur
- PS murmur
- PR murmur (severe)
- Pulsatile liver
- Peripheral oedema

## Respiratory, Clubbing %%
Causes of clubbing?
- Chronic suppurative disease (bronchiectasis, abscess)
- Lung carcinoma (not small cell)
- Cystic fibrosis
- Mesothelioma
- Mediastinal disease (thymoma, lymphoma, carcinoma)
- Infective endocarditis
- Cyanotic congenital heart disease
- Coeliac disease, inflammatory bowel disease
- Familial

## Respiratory, Bronchiectasis %%
Causes of bronchiectasis?
- Postinfective bronchial damage
- Mucociliary clearance defects: Cystic fibrosis, primary ciliary dyskinesia, Kartagener's syndrome, Young's syndrome
- Immunodeficiency: Primary immunoglobulin deficiency or secondary (HIV)
- Mechanical: Obstruction from tumour or foreign body
- Immunological: Allergic bronchopulmonary aspergillosis
$+ The MRCP PACES Handbook, Second Edition. S Ghafur, PK Judge, R Kitchen, S Blows. 2017 $$

## Respiratory, Transplantation %%
What are the criteria specific to Chronic Obstructive Pulmonary Disease in lung transplantation?
- FEV1 < 20% predicted
- BODE index â‰¥ 7
- Moderate to severe pulmonary hypertension
- pCO2 > 50 mmHg and/or pO2 < 60 mmHg
- Severe exarcebation with hypercapnic respiratory failure or frequent exarcebations
$+ TSANZ Clinical Guidelines for Organ Transplantation from Deceased Donors. 2017 p70 $$

## Respiratory, Transplantation %%
What are the criteria specific to Cystic Fibrosis in lung transplantation?
- Frequent hospitalisation
- FEV1 < 30% predicted with downward trajectory
- Increasing antibiotic dependence or resistance
- Life-threatening haemoptysis or pneumothorax
- Requirement for non-invasive ventilation
- Development of pulmonary hypertension
- pCO2 > 50 mmHg and/or pO2 < 60 mmHg
$+ TSANZ Clinical Guidelines for Organ Transplantation from Deceased Donors. 2017 p71 $$

## Respiratory, Transplantation %%
What are the criteria specific to Pulmonary Fibrosis in lung transplantation?
- In 6 months, Forced Vital Capacity -10% and Diffusing Capacity of Lungs for Carbon Monoxide -15%
- Development of pulmonary hypertension
- Hospitalisation because of respiratory decline, acute exarcebation or pneumothorax
- Significant exercise-associated desaturation or oxygen requirement
$+ TSANZ Clinical Guidelines for Organ Transplantation from Deceased Donors. 2017 p71 $$

## Respiratory, Transplantation %%
What are the criteria specific to Pulmonary Vascular diseases in lung transplantation?
- NYHA Class III or IV despite escalation of pulmonary vasodilator therapy
- Refractory or progressive right heart failure
- Mean right atrial pressure of > 15 mmHg, cardiac index < 2L/min/m2, & mean pulmonary arterial pressure > 50 mmHg
$+ TSANZ Clinical Guidelines for Organ Transplantation from Deceased Donors. 2017 p71 $$
